343 related articles for article (PubMed ID: 9513907)
21. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function.
Mathieson PW; Turner AN; Maidment CG; Evans DJ; Rees AJ
Lancet; 1988 Oct; 2(8616):869-72. PubMed ID: 2902317
[TBL] [Abstract][Full Text] [Related]
22. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
Ponticelli C; Passerini P
Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
[TBL] [Abstract][Full Text] [Related]
23. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials.
Imperiale TF; Goldfarb S; Berns JS
J Am Soc Nephrol; 1995 Feb; 5(8):1553-8. PubMed ID: 7756587
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic membranous nephropathy in the elderly.
Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
[TBL] [Abstract][Full Text] [Related]
25. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
Kanigicherla DAK; Hamilton P; Czapla K; Brenchley PE
Nephrology (Carlton); 2018 Jan; 23(1):60-68. PubMed ID: 27778424
[TBL] [Abstract][Full Text] [Related]
26. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA; Rovin BH; Agarwal AK; Spetie DN
Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
27. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
[TBL] [Abstract][Full Text] [Related]
28. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR
N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
[TBL] [Abstract][Full Text] [Related]
29. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.
Branten AJ; Reichert LJ; Koene RA; Wetzels JF
QJM; 1998 May; 91(5):359-66. PubMed ID: 9709470
[TBL] [Abstract][Full Text] [Related]
30. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
Kosmadakis G; Filiopoulos V; Smirloglou D; Skarlas P; Georgoulias C; Michail S
Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and treatment outcome of idiopathic membranous nephropathy in Chinese patients.
Tang S; Chan TM; Cheng IK; Lai KN
QJM; 1999 Jul; 92(7):401-6. PubMed ID: 10627890
[TBL] [Abstract][Full Text] [Related]
32. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis.
Lu W; Gong S; Li J; Luo H; Wang Y
Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997
[TBL] [Abstract][Full Text] [Related]
34. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
Muslimović A; Rasić S; Rebić D; Uncanin S
Med Arh; 2009; 63(4):187-90. PubMed ID: 20088170
[TBL] [Abstract][Full Text] [Related]
35. Treatment of idiopathic membranous nephropathy (IMN).
Alexopoulos E; Papagianni A
Ren Fail; 2000 Nov; 22(6):697-709. PubMed ID: 11104159
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of idiopathic membranous nephropathy].
Passerini P
G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
[TBL] [Abstract][Full Text] [Related]
39. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
Bruns FJ; Adler S; Fraley DS; Segel DP
Ann Intern Med; 1991 May; 114(9):725-30. PubMed ID: 2012353
[TBL] [Abstract][Full Text] [Related]
40. The advantages of immunosuppressive therapy in renal disease.
Zucchelli P
Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]